Announcements Trials

Browse Landscape

Phase

Phase 3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Esophageal Neoplasms 4 Esophageal Squamous Cell Carcinoma 3 Uterine Cervical Neoplasms 2 Lymphatic Metastasis 2 Triple Negative Breast Neoplasms 1 Recurrence 1 Neoplasm Metastasis 1 Melanoma 1 Lung Neoplasms 1 Head and Neck Neoplasms 1 Carcinoma, Squamous Cell 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Ductal, Breast 1

Interventions

Leucovorin 22 Fluorouracil 22 Gemcitabine 21 Capecitabine 21 Paclitaxel 20 Docetaxel 20 Irinotecan 15 Carboplatin 15 Radiosurgery 14 Oxaliplatin 13 Cisplatin 13 Bevacizumab 13 Zoledronic Acid 12 pembrolizumab 11 Radiotherapy 11 Fulvestrant 11 palbociclib 9 Pemetrexed 9 Drug Therapy 9 130-nm albumin-bound paclitaxel 9 Surgical Procedures, Operative 7 Letrozole 7 Ibandronic Acid 7 abemaciclib 6 Trastuzumab 6 Prednisone 6 Vinorelbine 5 Folfox protocol 5 Floxuridine 5 Doxorubicin 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Neoplasm Metastasis × TP protocol × Clear all

NCT00779714 2008-10-24

ChemoSensMM

University of Wuerzburg

Phase 3 Unknown

Melanoma, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡